Special Issue "Utilizing Advanced Tissue Engineering, 3D-Printed, and Stem-Cell-Based Technology for CNS Tissue Repair and Regeneration"
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Regenerative Medicine and Therapeutics".
Deadline for manuscript submissions: closed (10 June 2023) | Viewed by 376
Special Issue Editor
Interests: spinal cord injury repair; stem cell exosome therapy; 3D digital analysis of spinal microvessels; neurovascular regeneration
Special Issue Information
Dear Colleagues,
Due to differences between mammals' immune systems and the intricacy of their tissues, humans and mammals' neural tissues have a limited natural capacity for self-regeneration. Injuries to the central nervous system (CNS), including traumatic brain injury (TBI) and spinal cord injuries, are among the leading causes of disability and fatalities worldwide. There is still a lack of effective therapeutics that meet the clinical need for the treatment of CNS injuries. Tissue engineering technology has made significant progress in CNS fields, such as the design and synthesis of high biomimetic biomaterial scaffolds, organoid, and the application of 3D-printed and stem cells or stem-cell-derived exosome technology. Such findings have sped up the development of several novel CNS damage treatment methods.
This Special Issue aims to publish original research articles and reviews focusing on utilizing advanced tissue engineering, 3D-printed, and stem-cell-based technology for CNS tissue repair and regeneration. Preferred topics include but are not limited to the following:
- Novel materials and 3D-printed personalized scaffolds for CNS injury and repair;
- All type of stem cells and exosomes; novel cell-free-based therapy for CNS tissue repair;
- Organoid, neurovascular tissue engineering or spinal cord-like tissue application for CNS repair.
Dr. Yong Cao
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tissue engineering
- 3D printed
- stem cells
- exosome
- CNS injury
- organoid